121 related articles for article (PubMed ID: 3680559)
1. Pharmacokinetics of antituberculosis drugs in patients.
Israili ZH; Rogers CM; el-Attar H
J Clin Pharmacol; 1987 Jan; 27(1):78-83. PubMed ID: 3680559
[TBL] [Abstract][Full Text] [Related]
2. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
McIlleron H; Wash P; Burger A; Norman J; Folb PI; Smith P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1170-7. PubMed ID: 16569826
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
van Oosterhout JJ; Dzinjalamala FK; Dimba A; Waterhouse D; Davies G; Zijlstra EE; Molyneux ME; Molyneux EM; Ward S
Antimicrob Agents Chemother; 2015 Oct; 59(10):6175-80. PubMed ID: 26248378
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
BMC Infect Dis; 2015 Mar; 15():126. PubMed ID: 25887748
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
P Brock A; Isaza R; Egelund EF; Hunter RP; Peloquin CA
J Vet Pharmacol Ther; 2014 Oct; 37(5):472-9. PubMed ID: 24684601
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
Van Schalkwyk M; Bekker A; Decloedt E; Wang J; Theron GB; Cotton MF; Eke AC; Cressey TR; Shapiro DE; Bacon K; Knowles K; George K; Browning R; Chakhtoura N; Rungruengthanakit K; Wiesner L; Capparelli EV; Stek AM; Mirochnick M; Best BM;
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0073723. PubMed ID: 37882552
[TBL] [Abstract][Full Text] [Related]
7. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Gurumurthy P; Ramachandran G; Hemanth Kumar AK; Rajasekaran S; Padmapriyadarsini C; Swaminathan S; Bhagavathy S; Venkatesan P; Sekar L; Mahilmaran A; Ravichandran N; Paramesh P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4473-5. PubMed ID: 15504887
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Ruslami R; Nijland HM; Adhiarta IG; Kariadi SH; Alisjahbana B; Aarnoutse RE; van Crevel R
Antimicrob Agents Chemother; 2010 Mar; 54(3):1068-74. PubMed ID: 20038625
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Park JS; Lee JY; Lee YJ; Kim SJ; Cho YJ; Yoon HI; Lee CT; Song J; Lee JH
Antimicrob Agents Chemother; 2016 Jan; 60(1):92-8. PubMed ID: 26459901
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis.
Pinheiro VG; Ramos LM; Monteiro HS; Barroso EC; Bushen OY; Façanha MC; Peloquin CA; Guerrant RL; Lima AA
Braz J Infect Dis; 2006 Dec; 10(6):374-9. PubMed ID: 17420908
[TBL] [Abstract][Full Text] [Related]
14. Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
Mallikaarjun S; Wells C; Petersen C; Paccaly A; Shoaf SE; Patil S; Geiter L
Antimicrob Agents Chemother; 2016 Oct; 60(10):5976-85. PubMed ID: 27458223
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Mlotha R; Waterhouse D; Dzinjalamala F; Ardrey A; Molyneux E; Davies GR; Ward S
J Antimicrob Chemother; 2015; 70(6):1798-803. PubMed ID: 25759035
[TBL] [Abstract][Full Text] [Related]
16. The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
Malone RS; Fish DN; Spiegel DM; Childs JM; Peloquin CA
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1580-4. PubMed ID: 10228130
[TBL] [Abstract][Full Text] [Related]
17. The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.
Perlman DC; Segal Y; Rosenkranz S; Rainey PM; Remmel RP; Salomon N; Hafner R; Peloquin CA;
Clin Infect Dis; 2005 Dec; 41(11):1638-47. PubMed ID: 16267738
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Zítková L; Janků I; Tousek J; Papezová E; Stastná J
Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Tappero JW; Bradford WZ; Agerton TB; Hopewell P; Reingold AL; Lockman S; Oyewo A; Talbot EA; Kenyon TA; Moeti TL; Moffat HJ; Peloquin CA
Clin Infect Dis; 2005 Aug; 41(4):461-9. PubMed ID: 16028152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
